Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 176-201

  Reddy, Janardan K ^a   Chu, Ruiyin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ANTILIPEMIC AGENT; BETA GALACTOSIDASE; HYDROGEN PEROXIDE; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR;

ANIMAL CELL; CELL SPECIFICITY; CELL TYPE; CONFERENCE PAPER; DNA PROTEIN COMPLEX; GENE SEQUENCE; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CELL; MOUSE; NONHUMAN; PEROXISOME; PLANT CELL; PLEIOTROPY; PROMOTER REGION; RAT; TISSUE SPECIFICITY;

ANIMALIA;

EID: 0030464001     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18616.x     Document Type: Conference Paper

References (99)

1. DE DUVE, C. & P. BAUDHUIN. 1966. Microbodies (peroxisomes) and related particles. Physiol. Rev. 46: 323-357.
2. TOLBERT, N. E. 1981. Metabolic pathways in peroxisomes and glyoxysomes. Annu. Rev. Biochem. 50: 133-157.
3. REDDY, J. K. & G. P. MANNAERTS. 1994. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 14: 343-370.
4. LAZAROW, P. B. & C. DE DUVE. 1976. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. USA 73: 2043-2046.
5. HASHIMOTO, T. 1982. Individual peroxisomal β-oxidation enzymes. Ann. N.Y. Acad. Sci. 386: 5-12.
6. PURDUE, P. E. & P. B. LAZAROW. 1994. Peroxisomal biogenesis: Multiple pathways of protein import. J. Biol. Chem. 269: 30065-30068.
7. RACHUBINSKI, R. A. & S. SUBRAMANI. 1995. How proteins penetrate peroxisomes. Cell 83: 525-528.
8. REDDY, J. K. & N. D. LALWANI. 1983. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to human. CRC Crit. Rev. Toxicol. 12: 1-58.
9. LAZAROW, P. B. & H. W. MOSER. 1995. Disorders of peroxisome biogenesis. In The Metabolic Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, and A. D. Valle, Eds.: McGraw-Hill. New York. 2287-2324.
10. WANDERS, R. J. A., R. B. H. SCHUTGENS & P.G. BARTH. 1995. Peroxisomal disorders: A review. J. Neuropathol. Exper. Neurol. 54: 726-739.
11. REDDY, J. K., M. S. RAO & D. E. MOODY. 1976. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 36: 1211-1217.
12. REDDY, J. K., D. L. AZARNOFF & C. F. HIGNITE. 1980. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398.
13. REDDY, J. K. & M. S. RAO. 1992. Peroxisome proliferation and hepatocarcinogenesis. In Mechanisms of Carcinogenesis in Risk Identification, H. Vainio, P. N. Magee, D. B. McGregor and A. J. McMichael, Eds.: International Agency for Research on Cancer. Lyon. 225-235.
14. REDDY, J. K., J. R. WARREN, M. K. REDDY & N. D. LALWANI. 1982. Hepatic and renal effects of peroxisome proliferators: Biological implications. Ann. N. Y. Acad. Sci. 386: 81-110.
15. MOODY, D. E. & J. K. REDDY. 1976. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348. J. Cell Biol. 71: 768-780.
16. USUDA, N., M. K., REDDY, T. HASHIMOTO, M. S. RAO & J. K. REDDY. 1988. Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes. Lab. Invest. 58: 100-111.
17. YELDANDI, A. V., N. USUDA, R. CHU, F. ERFURTH & V. YELDANDI. 1995. Molecular analysis, subcellular localization and tissue distribution of enzymes involved in uric acid degradation. Acta Histochem. Cytochem. 28: 173-180.
18. YELDANDI, A. V., V. YELDANDI, S. KUMAR, C. V. N. MURTHY, X. WANG, K. ALVARES, M. S. RAO & J. K. REDDY. 1991. Molecular evolution of urate oxidase-encoding gene in hominoid primates: Nonsense mutations. Gene 109: 281-284.
19. YELDANDI, A. V., R. CHU, S. K. REDDY, J. PAN, N. USUDA, Y. LIN, M. S. RAO & J. K. REDDY. 1995. Functional expression and peroxisomal targeting of rat urate oxidase in monkey kidney cells. Gene Express. 5: 123-132.
20. NOVIKOFF, A. B. & S. GOLDFISCHER. 1969. Visualization of peroxisomes (microbodies) and mitochondria with diaminobenzidine. J. Histochem. Cytochem. 17: 675-680.
21. HESS, R., W. STAUBLI & W. RIESS. 1965. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208: 856-888.
22. REDDY, J. K. & T. P. KRISHNAKANTHA. 1975. Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate. Science 200: 787-789.
23. MOODY, D. E. & J. K. REDDY. 1978. Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxicol. Appl. Pharmacol. 45: 497-504.
24. ASHBY, J., A. BRADY, C. R. ELCOMBE, B. M. ELLIOT, J. ISHMAEL, J. ODUM, J. D. TUGWOOD, S. KETTLE & L. F. H. PURCHASE. 1994. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13: (Suppl. 2). S1-S117.
25. RAO, M. S., V. SUBBARAO, A. V. YELDANDI & J. K. REDDY. 1992. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res. 52: 2977-2979.
26. WARREN, J. R., V. F. SIMMON & J. K. REDDY. 1980. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]-thymidine and salmonella mutagenesis assays. Cancer Res. 40: 36-41.
27. RAO, M. S. & J. K. REDDY. 1987. Peroxisome proliferation and hepatocarcinogensis. Carcinogenesis 8: 631-636.
28. REDDY, J. K., M. K. REDDY, M. I. USMAN, N. D. LALWANI & M. S. RAO. 1986. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl)phthalate, and di(2-ethylhexyl)adipate with a hypolipidemic drug. Environ. Hlth. Perspec. 65: 317, 327.
29. REDDY, J. K., S. K. GOEL, M. R. NEMALI, J. J. CARRINO, T. G. LAFFLER, M. K. REDDY, S. J. SPERBECK, T. OSUMI, T. HASHIMOTO, N. D. LALWANI & M. S. RAO. 1986. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. USA 83: 1747-1751
30. 2α. J. Lipid Res. 31: 1477-1482.
31. MUERHOFF, A.S., K.J. GRIFFIN & E.F. JOHNSON. 1992. The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omegahydroxylase, by clofibric acid. J. Biol. Chem. 267: 19051-19053.
32. KAIKAUS, R. M., W. K. CHAN, N. LYSENKO, R. RAY, P. R. ORTIZ DE MONTELLANO & N. M. BASS. 1993. Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisome proliferators: mediation via the cytochrome P-450IVA1 -hydroxylase pathway. J. Biol. Chem. 268: 9593-9603.
33. GULICK, T., S. CRESCI, T. CAIRA, D. D. MOORE & D. P. KELLY. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91: 11012-11016.
34. GIL-GOMEZ, G., J. AYTE & F. G. HEGARDT. 1993. The rat mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme-A-synthase gene contains elements that mediate its multihormonal regulation and tissue specificity. Eur. J. Biochem. 213: 772-779.
35. REDDY, J. K. & M. S. RAO. 1986. Peroxisome proliferators and cancer: Mechanisms and implications. Trends Pharmacol. Sci. 7: 438-443.
36. LALWANI, N. D., W. E. FAHL & J. K. REDDY. 1983. Detection of nafenopin binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochem. Biophys. Res. Commun. 116: 388-393.
37. NEMALI, M. R., M. K. REDDY, N. USUDA, P. G. REDDY, L. D. COMEAU, M. S. RAO & J. K. REDDY. 1989. Differential induction and regulation of peroxisomal enzymes: Predictive value of peroxisomal proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol. 97: 72-87.
38. REDDY, J. K. & M. S. RAO. 1989. Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis. Mutat. Res. 214: 63-68.
39. NEMALI, M. R., N. USUDA, M. K. REDDY, R. OYASU, T. HASHIMOTO, T. OSUMI, M. S. RAO & J. K. REDDY. 1988. Comparison of constitutive and inducible levels of expression of peroxisomal β-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 48: 5316-5324.
40. ALVARES, K., C. FAN, S. S. DADRAS, A. V. YELDANDI, R. A. RACHUBINSKI, J. P. CAPONE, S. SUBRAMANI, P. M. IANNACCONE, M. SAMBASIVA RAO & J. K. REDDY. 1994. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice. Cancer Res. 54: 2303-2306.
41. VARANASI, U., R. CHU, Q. HUANG, R. CASTELLON, A. V. YELDANDI & J. K. REDDY. 1996. Identification of a human peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl-Coenzyme A oxidase gene. J. Biol. Chem. 271: 2147-2155.
42. PAN, J., U. VARANASI, R. CHU, S. DADRAS, M. S. RAO, J. K. REDDY & A. V. YELDANDI. 1996. Human peroxisomal fatty acyl-CoA oxidase gene promoter directs β-gal expression in male accessory sex glands. J. Histochem. Cytochem. In press.
43. ELCOMBE, C. R. & A. M. MITCHELL. 1986. Peroxisome proliferation due to di(2-ethyl-hexyl)phthalate (DEHP): Species differences and possible mechanisms. Environ. Hlth. Perspect. 70: 211-219.
44. REDDY, J. K., N. D. LALWANI, S. A. QURESHI, M. K. REDDY & C. M. MOEHLE. 1984. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. Am. J. Pathol. 114: 171-183.
45. BLAAUBOER, B. J., C. W. VAN-HOLSTEIN, R. BLEUMINK, W. C. MENNES, F. N. VAN-PEIT, S. H. YAP, J. F. VAN PCLT, A. A. VAN IERSEL, A. TIMMERMAN & B. P. SCHMID. 1990. The effects of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem. Pharmacol. 40: 521-528.
46. BENTLEY, P., I. CALDER, C. ELCOMBE, P. GRASSO, H. G. WIEGAND & D. A. STRINGER. 1993. Hepatic peroxisome proliferation. Food Chem. Toxicol. 31: 857-907.
47. HANEFELD, M., C. KEMMER & E. KADNER. 1983. Relationship between morphological changes and lipid-lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46: 239-246.
48. REDDY, J. K, R. L. JIRTLE, T. K. WATANABE, N. K. REDDY, G. MICHALOPOULOS & S. A. QURESHI. 1984. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res. 44: 2582-2589.
49. FELLER, D. R., Y. SINGH, V. R. SHIRHATTI, T. A. KOCAREK, C.-T. LIU & G. KRISHNA. 1987. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes. Hepatology 7: 508-516.
50. WATANABE, T., N. D. LALWANI & J. K. REDDY. 1985. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643, and di-(2-ethylhexyl)phthalate. Biochem. J. 227: 767-775.
51. GIOMETTI, C. S., J. TAYLOR, M. A. GEMMELL, S.L. TOLLAKSEN, N. D. LALWANI & J. K. REDDY. 1991. A comparative study of the effects of clofibrate, ciprofibrate, Wy-14,643 & di-(2-ethylhexyl)-phthalate on liver protein expression in mice. Appl. Theor. Electroph. 2: 101-107.
52. ISSKMANN, I. & S. GREEN. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
53. HUANG, Q., A. V. YELDANDI, K. ALVARES, H. IDE, J. K. REDDY & M. S. RAO. M. S. 1995. Localization of peroxisome proliferator-activated receptor in mouse and rat tissues and demonstration of its nuclear translocation in transfected CV-1 cells. Int. J. Oncol. 6: 307-312.
54. BRAISSANT, O., F. FOUFELLE, C. SCOTTO, M. DAUCA & W. WAHLI. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR α, -β and -γ in the adult rat. Endocrinology 137: 354-366.
55. DREYER, C., G. KREY, H. KELLER, F. GIVEL, G. HELFTENBIEN & W. WAHLI 1992. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887.
56. SHER, T., H. F. YI, W. MCBRIDE & F. J. GONZALEZ. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32: 5598-5604.
57. ZHU, Y., K. ALVARES, Q. HUANG, M. S. RAO, J. K. REDDY. 1993. Cloning of a new member of the peroxisome proliferator activated receptor gene family from mouse liver. J. Biol. Chem. 268: 26817-26820.
58. TONTONOZ, P., E. HU, R.A. GRAVES, A.I. BUDAVARI & B.M. SPIEGELMAN. 1994. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes & Dev. 8: 1224-1234.
59. KLIEWER, S. A., B. M. FORMAN, B. BLUMBERG, E. S. ONG, U. BORGMEYER, D. J. MANGELSDORI. K. UMESONO & R. M. EVANS. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91: 7355-7359.
60. SCHMIDT, A., N. ENDO, S. J. RUTLEDGE, R. VOGEL, D. SHINAR & G.A. RODAN. 1992. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6: 1634-1641.
61. GOTTLICHER, M., E. WIDMARK, Q. LI & J. A. GUSTAFSSON. 1992. Fatty acids activate chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89: 4653-4657.
62. SPERLO, C., P. POGNONEC, R. SALADIN, J. AUWERX & K. BOULUKOS. 1995. Isolation and characterization of the hamster peroxisomal proliferator activated receptor hPPARγ, a member of the nuclear hormone receptor superfamily. Gene 162: 297-302.
63. ZHU, Y., C. QI, J. R. KORENBERG, Z.-N. CHEN, D. NOYA, M. S. RAO & J. K. REDDY. 1995. Structural organization of mouse peroxisome proliferator-activated receptor (mPPARK-γ) gene: Alternative promoter use and different splicing yield two mPPAR-γ isoforms. Proc. Natl. Acad. Sci. USA 92: 7921-7925.
64. LEE, S. S.-T., T. PINEAU, J. DRAGO, E. J. LEE, J. W. OWENS, D. L. KROETZ, P. M. FERNANDEZ-SALGUERO, H. WESTPHAL & F. J. GONZALEZ. 1995. Targeted disruption of the isoform of the peroxisomal proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
65. HUANG, Q., K. ALVARES, R. CHU, C. A. BRADFIELD & J. K. REDDY. 1994. Association of peroxisome proliferator-activated receptor and Hsp72. J. Biol. Chem. 269: 8493-8497.
66. LALWANI, N. D., K. ALVARES, M. K. REDDY, M. N. REDDY, I. PARIKH & J. K. REDDY. 1987. Peroxisome proliferator-binding protein: Identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver. Proc. Natl. Acad. Sci. USA 84: 5242-5246.
67. TONTONOZ, P., E. HU, B. M. SPIEGELMAN. 1994. Stimulation of adipogenesis in fibroblasts by PPAR-γ2, a lipid-activated transcription factor. Cell 79: 1147-1156.
68. 2 is a ligand for the adipocyte determination factor PPARγ Cell 83: 803-812.
69. TUGWOOD, J. D., I. ISSEMANN, R.G. ANDERSON, K. R. BUNDELL, W. L. MCPHEAT & S. GREEN. 1992. The mouse peroxisome proliferator activated receptor recognizes response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
70. MANGELSDORF, D. J., C. THUMMEL, M. BEATO, P. HERRLICH, G. SCHUTZ, K. UMESONO, B. BLUMBERG, P. KASTNER, M. MARK, P. CHAMBON & R. M. EVANS. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
71. CHU, R., Y. LIN, M. S. RAO & J. K. REDDY. 1995. Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 270: 29636-29639.
72. SCHOONJANS, K., M. WATANABE, H. SUZUKI, A. MAHFOUDI, G. KREY, W. WAHLI, P. GRIMALDI, B. STAELS, T. YAMAMOTO & J. AUWERX. 1995. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator reponse element in the C promoter. J. Biol. Chem. 270: 19269-19276.
73. ALDRIDGE, T. C., J. D. TUGWOOD & S. GREEN. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306: 473-479.
74. PALMER, C. N. A., M.-H. HSU, K. J. GRIFFIN & E. F. JOHNSON. 1995. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270: 16114-16121.
75. CASTELEIN, H., T. GULICK, P. E. DECLERCQ, G. P. MANNAERTS, D. D. MOORE & M. I. BAES. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269: 26754-26758.
76. SWEETSER, D. A., E. H. BIRKENMEIER, I. J. KLISAK, S. ZOLLMAN, R. S. SPARKES, T. MOHANDAS, A. J. LUSIS & J. I. GORDON. 1987. The human and rodent intestinal fatty acid binding protein genes: A comparative analysis of their structure, expression, and linkage relationships. J. Biol. Chem. 262: 16060-16071.
77. DIMONSON, O. D. & V. IWANU. 1995. Genomic organization and promoter sequence of a gene encoding a rat liver-specific type-I transport protein. Gene 154: 243-247.
78. COSTA, R. H., E. LAI, D .R. GRAYSON & J. E. DARNELL JR. 1988. The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites. Mol. Cell. Biol. 8: 81-90.
79. VU-DAC, N., K. SCHOONJANS, B. LAINE, J.-C. FRUCHART, J. AUWERX & B. STAELS. 1994. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its reponse element. J. Biol. Chem. 269: 31012-31018.
80. VU-DAC, N., K. SCHOONJANS, V. KOSYKH, J. DALLONGEVILLE, J.-C. FRUCHART, B. STAELS & J. AUWERX. 1995. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96: 741-750.
81. LEFF, T., K. REUE, A. MELIAN, H. CULVER & J. L. BRESLOW. 1989. A regulatory element in the ApoCIII promoter that directs hepatic specific transcription binds to proteins in expression and nonexpressing cell types. J. Biol. Chem. 264: 16132-16137.
82. HERTZ, R., J. BISHARA-SHIEBAN & J. BAR-TANA. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs: Suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
83. WUNHOLDS, J., E. MULLER & G. AB. 1991. Oestrogen facilitates the binding of ubiquitous and liver-enriched nuclear proteins to the apoVLDL II promoter in vivo. Nucl. Acids Res. 19: 33-47.
84. TONTONOZ, P., E. HU, J. DEVINE, E. G. BEALE & B. M. SPIEGELMAN. 1995. PPARγ regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15: 351-357.
85. HUAN, B., M. J. KOSOVSKY & A. SIDDIQUI. 1995. Retinoid X receptor transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J. Virol. 69: 547-551.
86. KLIEWKR, S. A., K. UMESONO, D. J. NOONAN, R. A. HEYMAN & R. M. EVANS. 1992. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (London) 358: 771-774.
87. MIYATA, K., B. ZHANG, S. L. MARCUS, J. P. CAPONE & R. A. RACHUBINSKI. 1993. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisomeresponsive element and antagonizes peroxisome proliferator-mediated signaling. J. Biol. Chem. 268: 19169-19172.
88. JUGE-AUBRY, C. E., A. GORLA-BAJSZCZAK, A. PERNIN, T. LEMBERGER, W. WAHLI, A. G. BURGER & C. A. MEIER. 1995. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J. Biol. Chem. 270: 18117-18122.
89. 3 signaling pathways. Proc. Natl. Acad. Sci. USA 92: 11593-11597.
90. LEE, J. W., F. RYAN, J. C. SWAFFIELD, S. A. JOHNSTON & D. D. MOORE. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374: 91-94.
91. ONATE, S.A., S. Y. TSAI, M. J. TSAI & B. W. O'MALLEY. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
92. HORLEIN, A. J., A. M. NAAR, T. HEINZEL, J. TORCHIA, B. GLOSS, R. KUROKAWA, A. RYAN, Y. KAMEI, M. SODERSTROM, C. K. GLASS & M. G. ROSENFELD. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404.
93. CHEN, J. D. & R. M. EVANS. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
94. ZHU, Y., C. QI, C. CALANDRA, M. S. RAO & J. K. REDDY. 1996. Cloning and identification of mouse SRC-1 as the coactivator for mouse peroxisome proliferator-activated receptor (mPPARα). Submitted.
95. CHU, R., Y. LIN, M. S. RAO & J. K. REDDY. 1996. Cloning and identification of deoxyuridine triphosphate nucleotidohydrolase as an inhibitor of rat peroxisome proliferator-activated receptor a (PPARα). J. Biol. Chem. 271. In press.
96. RAO, M. S. & J. K. REDDY. 1996. Hepatocarcinogenicity of peroxisome proliferators. Ann. N.Y. Acad. Sci. This volume.
97. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sci. USA 92: 7080-7084.
98. 2-generating peroxisomal urate oxidase. Submitted.
99. FAN, C.-Y, J. PAN, R. CHU, D. LEE, K. D. KLUCKMAN, N. USUDA, I. SINGH, A. V. YELDANDI, M. S. RAO, N. MAEDA & J. K. REDDY. 1996. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271: 24698-24710.